Hrt Risks

Have you heard a lot about associations between hormone replacement therapy and breast cancer development? Would you like to get to know more about hormone replacement risk therapy for breast cancer survivor? Improved survival with women with breast cancer means that more breast cancer survivors are going through menopause that cause severe symptoms, such as hot flashes, night sweats and loss of sexual desire. Hormone replacement therapy is given to women after menopause to replace the hormones no longer provided by the ovaries and the list of potential benefits of HRT is impressive, but risks of hormone replacement therapy also take place. Recent studies proved that type and duration of using HRT affects risk of development of breast health problems. Hormone replacement therapy risk is especially high at the women who were diagnosed with breast cancer as HRT can cause breast cancer recurrence and death.

Studies found that women, who take HRT to relieve menopausal symptoms, have higher risk of development of breast cancer. If to speak about hormone replacement therapy risk and benefit, it may release such advantages as decreased risk of Alzheimer’s disease, colorectal cancer and cataracts; less of need for false teeth and less severe osteoarthritis. Many researches have analyzed risk of hormone replacement therapy, no one study would not be enough strong to provide conclusive evidence that breast cancer survivors avoid HRT. Some risks of HRT materials conclude that even short-term use of HRT posed an unacceptably high risk of breast cancer recurrence. It is now well established that estrogen-progestin replacement therapy is associated with an elevation of breast cancer development.

In order to lower hormone replacement therapy risks, doctors advice to perform mammography before the beginning of HRT and then every two years in the absence of important risk factors for breast cancer. The indication of hormone replacement therapy has to be discussed every year and some pauses must be planned. Cancer diagnosed in women who have never used hormone replacement therapy tended to be less advanced clinically that those diagnosed in never-users. Estimates of the relative HRT risks associated with breast cancer were obtained by the stratification of all analyses by study, age at diagnoses, time since menopause, body mass index, parity and the age of the woman when her first child was born. Find out more about hormone replacement risk therapy, benefits and risks of hormone replacement therapy and effective methods to reduce hormone replacement therapy risk from trusted information featured by our website.